Evidence map›Paper›PMID 24757671›Full record

ReviewBioMed research international2014

Current and future lymphatic imaging modalities for tumor staging.

Ghulam Murtaza, Kuo Gao, Tiegang Liu, Imran Tariq, Ashif Sajjad, Muhammad Rouf Akram, Meiying Niu, Guokai Liu, Zahid Mehmood, Guihua Tian

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in BioMed research international, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ghulam MurtazaDepartment of Pharmacy, COMSATS Institute of Information Technology, Abbottabad 22060, Pakistan.ORCID 0000-0001-5649-5768
Kuo GaoBeijing University of Chinese Medicine, 11 Bei San Huan Dong Lu, Chao Yang District, Beijing 100029, China.
Tiegang LiuBeijing University of Chinese Medicine, 11 Bei San Huan Dong Lu, Chao Yang District, Beijing 100029, China.
Imran TariqUniversity College of Pharmacy, University of the Punjab, Lahore 54000, Pakistan.
Ashif SajjadInstitute of Biochemistry, University of Balochistan, Quetta 87300, Pakistan.
Muhammad Rouf AkramDepartment of Pharmacy, University of Sargodha, Sargodha 40100, Pakistan.ORCID 0000-0001-9899-8988
Meiying NiuBeijing University of Chinese Medicine, 11 Bei San Huan Dong Lu, Chao Yang District, Beijing 100029, China.
Guokai LiuBeijing University of Chinese Medicine, Dongzhimen Hospital, Dong Cheng District, Beijing 100700, China.
Zahid MehmoodInstitute of Biochemistry, University of Balochistan, Quetta 87300, Pakistan.
Guihua TianBeijing University of Chinese Medicine, Dongzhimen Hospital, Dong Cheng District, Beijing 100700, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor progression is supported by the lymphatic system which should be scanned efficiently for tumor staging as well as the enhanced therapeutic outcomes. Poor resolution and low sensitivity is a limitation of traditional lymphatic imaging modalities; thus new noninvasive approaches like nanocarriers, magnetic resonance imaging, positron-emission tomography, and quantum dots are advantageous. Some newer modalities, which are under development, and their potential uses will also be discussed in this review.

Indexed as

AnimalsContrast MediaHumansNeoplasmsNeoplasm StagingPositron-Emission TomographyQuantum DotsRadiographyContrast Media

Identifiers

PMID24757671
PMCPMC3976799

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.